Vision, Mission & Business Model
To be the leader in the GCC and the Middle East in localizing cutting edge clinical diagnostic technologies based on mass spectrometry and next generation sequencing, and to be the premier local partner for innovation and advancement in clinical and pharmaceutical research.
- Improve patient outcome by localizing special critical assays deriving a reduction in time of result to doctors, and consequently enhancing their medical decisions.
- Deliver the highest level of quality results by employing Gold Standard techniques, and adhering to the uppermost international accreditation standards.
- Provide access to local scientists the know-how to develop and train on cutting-edge diagnostics technologies.
- Collaborate with the academic and pharmaceutical research institutions in the GCC by providing access to novel analytical techniques.
- Build partnerships with local hospitals and laboratories in the region to our technologies to improve patient care.
- Introduce the latest technologies and know-how in medical diagnostics and clinical testing research to the region.
- Develop and manage our network of specialized laboratories in the GCC and Middle East.